The quarterly "Transformation" bingo card is getting a little too predictable

hi · 2026-05-10T05:03:12.002Z

Another day, another town hall where the slides are brighter than the leadership’s grasp on reality. We’re being "streamlined"—a polite euphemism for finding out our roles have been redundant since the last reorg three months ago. It’s truly an art form: watching senior leadership perform a high-wire act of corporate double-speak, trying to convince us that cutting back-office support while pushing for more aggressive clinical milestones is somehow "synergistic." We’re told to focus on the pipeline, yet the internal infrastructure is held together by Slack channels and the hope that the legacy systems don’t collapse before the next earnings call. The transparency here is like a house of mirrors—plenty of reflections, but you’ll never actually see the exit. I’m done trying to parse the subtext of a vague "strategic pivot." Just tell us who’s left to carry the water and be done with it. I’ve stopped refreshing the org chart; it’s basically just a daily obituary for my department’s relevance.

The quarterly "Transformation" bingo card is getting a little too predictable | Pfizer Discussions